SEEK ONES SINGLE MOLECULE TECHNOLOGIES PTE. LTD.

We're focusing on generating nanoparticles, each with exactly one site for analyte molecule capture. This allows for single molecules to be captured with a controlled spacing and also at high density, which is crucial for tcehnologies like DNA sequencing and the broader single molecule analysis, such as the incipient

SEEK ONES SINGLE MOLECULE TECHNOLOGIES PTE. LTD. is active in the medtech, biotech, nanotechnology space based in Singapore, founded in 2024.

Profile

We're focusing on generating nanoparticles, each with exactly one site for analyte molecule capture. This allows for single molecules to be captured with a controlled spacing and also at high density, which is crucial for tcehnologies like DNA sequencing and the broader single molecule analysis, such as the incipient field large scale single molecule proteomics.

For illustration, even in the best case scenario, roughly 30% of a flowcell used for DNA sequencing is unproductive due to too-high (and thus optically unresolvable) or too-low (thus wasting space) single template capture density. Given Illumina's consumables revenue of US$2.5 Billion, if we're able to boost data output by 30% using controlled template spacing using said single capture nanoparticles, we could create hundreds of millions of dollars worth of additional sequencing data without any additional effort. This and related improvements are the goals we're trying to attain.

Please see our website for details and contact info: seek1s.com

Its activity falls under medtech, biotech, nanotechnology; the profile below is assembled from public directory data.

The company is recorded as being based in Singapore.

Its current recorded stage is Startup SG directory startup.

Recorded headcount: 1 - 10 employees.

Website: seek1s.com